Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sonidegib and Lenalidomide Maintenance Post-ASCT for Multiple Myeloma
NCT02086552Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Jan 2014
- Primary completion
- Jan 2018
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 2 trial of sonidegib in multiple myeloma (MM), sponsored by Mayo Clinic. Started Jan 2014; status: completed.
02
Drugs
sonidegib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02086552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02086552.